Literature DB >> 20067534

Insulin-like growth factor I messenger RNA and protein are expressed in the human lymph node and distinctly confined to subtypes of macrophages, antigen-presenting cells, lymphocytes and endothelial cells.

Dominique Oberlin1, Christian Fellbaum, Elisabeth Eppler.   

Abstract

Insulin-like growth factor I (IGF-I) is a potent hormone that stimulates growth and differentiation and inhibits apoptosis in numerous tissues. Preliminary evidence suggests that IGF-I exerts differentiating, mitogenic and restoring activities in the immune system but the sites of synthesis of local IGF-I are unknown. Identification of these sites would allow the functional role of local IGF-I to be clarified. The presence of IGF-I in non-immune cells suggests that it acts as a trophic factor, while its occurrence in subtypes of lymphocytes or antigen-presenting cells indicates paracrine/autocrine direct regulatory involvement of IGF-I in the human immune response. The present study investigated the location of IGF-I messenger RNA and protein on archival human lymph node samples by in situ hybridization, immunohistochemistry and double immunofluorescence staining using an IGF-I probe and antisera specific for human IGF-I and CD3 (T lymphocytes), CD20 (B lymphocytes), CD68 (macrophages), CD21 (follicular dendritic cells), S100 (interdigitating dendritic cells) and podoplanin (fibroblastic reticular cells). Numerous cells within the B- and T-cell compartments expressed the IGF-I gene, and the majority of these cells were identified as macrophages. Solitary follicular dendritic cells exhibited IGF-I. A few T lymphocytes, and no B lymphocytes, contained IGF-I immunoreactive material. Furthermore, IGF-I immunoreactive cells outside the follicles that did not react with CD3, CD20, S100 or podoplanin markers were identified as high-endothelial venule (HEV) cells. From this we conclude that the main task of IGF-I in human non-tumoral lymph node may be autocrine and paracrine regulation of the differentiation, stimulation and survival of lymphocytes, antigen-presenting cells and macrophages and the differentiation and maintenance of HEV cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20067534      PMCID: PMC2770682          DOI: 10.1111/j.1365-2567.2009.03136.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  54 in total

1.  Microvascular changes in lymph nodes draining skin allografts.

Authors:  N D Anderson; A O Anderson; R G Wyllie
Journal:  Am J Pathol       Date:  1975-10       Impact factor: 4.307

2.  Liver-derived IGF-I regulates GH secretion at the pituitary level in mice.

Authors:  K Wallenius; K Sjögren; X D Peng; S Park; V Wallenius; J L Liu; M Umaerus; H Wennbo; O Isaksson; L Frohman; R Kineman; C Ohlsson; J O Jansson
Journal:  Endocrinology       Date:  2001-11       Impact factor: 4.736

Review 3.  Control of T cell viability.

Authors:  Philippa Marrack; John Kappler
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

4.  IGF-I in human breast cancer: low differentiation stage is associated with decreased IGF-I content.

Authors:  E Eppler; J Zapf; N Bailer; U G Falkmer; S Falkmer; M Reinecke
Journal:  Eur J Endocrinol       Date:  2002-06       Impact factor: 6.664

Review 5.  Insulin-like growth factor I actions on steroidogenesis.

Authors:  P G Chatelain; M O Avallet; M Nicolino; H Lejeune; A Clark; F Chuzel; A Penhoat; J M Saez
Journal:  Acta Paediatr Suppl       Date:  1994-04

Review 6.  The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency.

Authors:  K Dorshkind; N D Horseman
Journal:  Endocr Rev       Date:  2000-06       Impact factor: 19.871

7.  Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I.

Authors:  K Binz; P Joller; P Froesch; H Binz; J Zapf; E R Froesch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Insulin-like growth factor secretion by human B-lymphocytes: a comparison of cells from normal and pygmy subjects.

Authors:  T J Merimee; M B Grant; C M Broder; L L Cavalli-Sforza
Journal:  J Clin Endocrinol Metab       Date:  1989-11       Impact factor: 5.958

9.  Immunohistochemical localization of insulin-like growth factor I in the adult rat.

Authors:  H A Hansson; A Nilsson; J Isgaard; H Billig; O Isaksson; A Skottner; I K Andersson; B Rozell
Journal:  Histochemistry       Date:  1988

10.  The indirect participation of growth hormone in the thymocyte proliferation system.

Authors:  M Yamada; F Hato; Y Kinoshita; K Tominaga; Y Tsuji
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1994-03       Impact factor: 1.770

View more
  8 in total

Review 1.  Spleen: A new role for an old player?

Authors:  Giovanni Tarantino; Silvia Savastano; Domenico Capone; Annamaria Colao
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

2.  Overload training inhibits phagocytosis and ROS generation of peritoneal macrophages: role of IGF-1 and MGF.

Authors:  Weihua Xiao; Peijie Chen; Ru Wang; Jingmei Dong
Journal:  Eur J Appl Physiol       Date:  2012-05-17       Impact factor: 3.078

3.  Infectious diseases and immunological responses in adult subjects with lifetime untreated, congenital GH deficiency.

Authors:  Viviane C Campos; Mônica R Barrios; Roberto Salvatori; Roque Pacheco de Almeida; Enaldo V de Melo; Ana C S Nascimento; Amélia Ribeiro de Jesus; Manuel H Aguiar-Oliveira
Journal:  Endocrine       Date:  2016-08-03       Impact factor: 3.633

Review 4.  The role of obesity in gastrointestinal cancer: evidence and opinion.

Authors:  Claire L Donohoe; Naoimh J O'Farrell; Suzanne L Doyle; John V Reynolds
Journal:  Therap Adv Gastroenterol       Date:  2014-01       Impact factor: 4.409

5.  Activated macrophages as a feeder layer for growth of resident cardiac progenitor cells.

Authors:  Diana E Sepúlveda; Patricia Cabeza Meckert; Paola Locatelli; Fernanda D Olea; Néstor G Pérez; Oscar A Pinilla; Romina G Díaz; Alberto Crottogini; Rubén P Laguens
Journal:  Cytotechnology       Date:  2014-11-29       Impact factor: 2.058

6.  Individuals with isolated congenital GH deficiency due to a GHRH receptor gene mutation appear to cope better with SARS-CoV-2 infection than controls.

Authors:  Manuela A Melo; Lysandro P Borges; Roberto Salvatori; Daniela R V Souza; Hertz T Santos-Júnior; José M de R Neto; Viviane C Campos; Aryanne A Santos; Carla R P Oliveira; Grazielly B da Invenção; Vanderlan O Batista; Igor L S Matos; Cynthia S Barros-Oliveira; Kezia A Dos Santos; Elenilde G Santos; Nicolas A A Souza; Enaldo V Melo; Pamela C Borges; Saulo E F S Santos; Brenda M de Oliveira; Alécia A Oliveira-Santos; Amélia R de Jesus; Manuel H Aguiar-Oliveira
Journal:  Endocrine       Date:  2021-04-16       Impact factor: 3.633

Review 7.  Endocrine and Local IGF-I in the Bony Fish Immune System.

Authors:  Anne-Constance Franz; Oliver Faass; Bernd Köllner; Natallia Shved; Karl Link; Ayako Casanova; Michael Wenger; Helena D'Cotta; Jean-François Baroiller; Oliver Ullrich; Manfred Reinecke; Elisabeth Eppler
Journal:  Biology (Basel)       Date:  2016-01-26

8.  Macrophages From Subjects With Isolated GH/IGF-I Deficiency Due to a GHRH Receptor Gene Mutation Are Less Prone to Infection by Leishmania amazonensis.

Authors:  Mônica R Barrios; Viviane C Campos; Nalu T A Peres; Laís L de Oliveira; Rodrigo A Cazzaniga; Márcio B Santos; Murilo B Aires; Ricardo L L Silva; Aline Barreto; Hiro Goto; Roque P Almeida; Roberto Salvatori; Manuel H Aguiar-Oliveira; Amélia M R Jesus
Journal:  Front Cell Infect Microbiol       Date:  2019-08-30       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.